However, robust ERK1/2 inhibition by small molecule inhibitors or RKIP (unphosphorylated RKIPS153A), although potentially effective against cancer, also leads to the apoptosis of cardiomyocytes, cells with very limited regeneration capacity. The gene discussed is PEBP1; the disease is cancer.